Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses

Abstract Background Shorter duration of symptoms before remdesivir has been associated with better outcomes. Our goal was to evaluate variables associated with the need of ICU admission in a cohort of hospitalized patients for COVID-19 under remdesivir including the period from symptoms onset to rem...

Полное описание

Библиографические подробности
Главные авторы: Rodrigo Alonso-Navarro, Margarita Ramírez, Mar Masiá, Roger Paredes, Rocío Montejano, Marina Povar-Echeverria, Jordi Carratalà, Miguel Salavert, Enrique Bernal, Carlos Dueñas, Juan Flores, Francisco Fanjul, Isabel Gutiérrez, Verónica Rico, Lourdes Mateu, Julen Cadiñanos, Juan Berenguer, Alex Soriano
Формат: Статья
Язык:English
Опубликовано: BMC 2023-05-01
Серии:BMC Infectious Diseases
Предметы:
SARS-CoV-2
Remdesivir
Days from symptoms onset
ICU
Progression
Online-ссылка:https://doi.org/10.1186/s12879-023-08222-y

Схожие документы

Схожие документы